Jun 2026 (Q2 FY26) — Aug 6, 2026
Skin Health Systems Inc. Q2 FY26 — Mixed Quarter with Strong Profitability and Strategic Progress
Read the full callSkinHealth Systems (SKIN) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
SkinHealth Systems earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 72.1 | −7.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 5.0 | +8.4 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -2.7 | −113.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$12.6 +9.00% · +$1.04
Performance +707.7% 1Y
1Y: $1.56 on 14 Oct 2025 → $12.6. High $12.6 (15 Oct 2026), low $0.58 (8 May 2026).
- Previous close
- $11.56
- 52-week range
- $0.58 – $12.6
- One year
- +745.64%
Overview
- Symbol
- SKIN
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
SkinHealth Systems earnings calls (SKIN)
Financials
What the filings say
Net profit, year on year: −114% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 79 | 83 | 70 | 78 | 71 | 82 | 65 | 72 |
| Operating profit | -22 | -7 | -12 | -3 | -6 | 0 | -2 | 4 |
| Operating margin | −27.3% | −8.6% | −17.3% | −3.5% | −8.8% | 0.2% | −2.8% | 5.0% |
| Interest | 2 | 2 | 2 | 4 | 6 | 6 | 6 | 6 |
| Profit before tax | -16 | -12 | -9 | 19 | -11 | -5 | -7 | -1 |
| Tax rate | −11.9% | 11.8% | −9.7% | −5.3% | −3.6% | −68.5% | 2.7% | −82.7% |
| Net profit | -18 | -10 | -10 | 20 | -11 | -8 | -7 | -3 |
| EPS ($ per share) | -0.15 | — | -0.08 | 0.16 | -0.09 | — | -0.05 | -0.02 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | -44 | -419 | -379 | -479 | -508 | -517 |
| Total liabilities | — | 253 | 917 | 836 | 870 | 634 | 439 |
| Fixed assets | — | 9 | 16 | 18 | 14 | 6 | 3 |
| Total assets | — | 223 | 1,219 | 1,003 | 929 | 686 | 500 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 2 | -12 | -28 | -107 | 22 | 16 | 37 |
| Cash from investing | -12 | -4 | -38 | -19 | -32 | -7 | -5 |
| Cash from financing | 15 | 18 | 959 | -205 | -37 | -158 | -175 |
| Capital expenditure | -9 | -4 | -11 | -11 | -4 | -1 | -0 |
| Free cash flow | -7 | -16 | -40 | -117 | 18 | 15 | 37 |
Insider filings
14 filings between Nov 1, 2025 and Oct 9, 2026.
Open market
decisions to buy or sellNobody bought or sold SKIN on the open market in this window. The filings below are 5 awards and 9 tax withholdings.
Compensation
not trading decisions- 5
- Award — granted as compensation
- 9
- Tax withheld — shares kept back by the company to cover tax
Latest filings (33)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Malha Pedro Bruno Ferreira President and CEO | Tax withheld | 99,742 | $54.9K |
| Oct 9, 2026 | Malha Pedro Bruno Ferreira President and CEO | Tax withheld | 78,045 | $42.9K |
| Aug 10, 2026 | MONAHAN MICHAEL P. Chief Financial Officer | Tax withheld | 32,357 | $20.7K |
| Apr 9, 2026 | Lewis Sheri CSO and COO | Tax withheld | 24,904 | $22.9K |
| Apr 9, 2026 | MONAHAN MICHAEL P. Chief Financial Officer | Tax withheld | 26,776 | $24.6K |
| Mar 20, 2026 | MONAHAN MICHAEL P. Chief Financial Officer | Award | 746,681 | — |
| Mar 20, 2026 | Malha Pedro Bruno Ferreira President and CEO | Award | 2,654,867 | — |
| Mar 20, 2026 | Lewis Sheri CSO and COO | Award | 746,681 | — |
| Mar 20, 2026 | Menezes Ronald Chief Revenue Officer | Award | 746,681 | — |
| Mar 17, 2026 | Lewis Sheri CSO and COO | Tax withheld | 51,883 | $60.7K |
| Mar 17, 2026 | Menezes Ronald Chief Revenue Officer | Tax withheld | 61,471 | $71.9K |
| Mar 17, 2026 | MONAHAN MICHAEL P. Chief Financial Officer | Tax withheld | 58,573 | $68.5K |
| Nov 13, 2025 | SCHAISON PHILIPPE Director | Award | 57,692 | — |
| Nov 1, 2025 | Menezes Ronald Chief Revenue Officer | Tax withheld | 46,426 | $66.4K |
| Oct 9, 2025 | Malha Pedro Bruno Ferreira President and CEO | Award | 1,228,846 | $1.92M |
| Oct 9, 2025 | Malha Pedro Bruno Ferreira President and CEO | Award | 961,538 | $1.50M |
| Aug 10, 2025 | MONAHAN MICHAEL P. Chief Financial Officer | Tax withheld | 32,357 | $61.2K |
| Jun 16, 2025 | Miller Brian Christopher Director | Award | 73,051 | — |
| Jun 16, 2025 | Kerrick Michelle C. Director | Award | 73,051 | — |
| Jun 16, 2025 | SAUNDERS BRENT L Director | Award | 73,051 | — |
| Jun 16, 2025 | Gruber Desiree Director | Award | 73,051 | — |
| Jun 16, 2025 | Schillinger Doug K. Director | Award | 73,051 | — |
| Jun 16, 2025 | FANNING STEPHEN J Director | Award | 73,051 | — |
| Jun 1, 2025 | MONAHAN MICHAEL P. Chief Financial Officer | Tax withheld | 24,290 | $39.6K |
| Apr 9, 2025 | Lewis Sheri CSO and COO | Tax withheld | 31,296 | $33.8K |
| Apr 9, 2025 | BECK MARLA MALCOLM President and CEO | Tax withheld | 92,981 | $100.4K |
| Apr 9, 2025 | MONAHAN MICHAEL P. Chief Financial Officer | Tax withheld | 26,776 | $28.9K |
| Mar 17, 2025 | Menezes Ronald Chief Revenue Officer | Award | 639,204 | $843.7K |
| Mar 17, 2025 | Lewis Sheri CSO and COO | Award | 639,204 | $843.7K |
| Mar 17, 2025 | MONAHAN MICHAEL P. Chief Financial Officer | Award | 639,204 | $843.7K |
| Mar 17, 2025 | BECK MARLA MALCOLM President and CEO | Award | 1,832,386 | $2.42M |
| Dec 1, 2024 | MONAHAN MICHAEL P. Chief Financial Officer | Tax withheld | 24,227 | $35.9K |
| Nov 20, 2024 | Gruber Desiree Director | Sale | 14,663 | $22.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for SkinHealth Systems Inc.
Free account. Everything above stays public.
Write why you follow SkinHealth Systems Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading